| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $25.6M | -39.5% |
| SG&A Expense | $40.8M | +37.6% |
| Operating Income | -$70.6M | -3.8% |
| Pre-tax Income | -$66.6M | -8.8% |
| Income Tax | -$175K | -297.7% |
| Net Income | -$66.4M | -8.8% |
| EPS (Basic) | -$1.64 | -5.8% |
| EPS (Diluted) | -$1.64 | -5.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.5M | -36.3% |
| Current Assets | $77.8M | -38.1% |
| Total Assets | $98.2M | -38.8% |
| Current Liabilities | $10.0M | -36.0% |
| Total Liabilities | $23.9M | -20.9% |
| Stockholders' Equity | $74.2M | -42.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.0M | -65.8% |
| Capital Expenditures | $37K | -95.9% |
| Investing Cash Flow | $416K | +146.6% |
| Financing Cash Flow | $2K | -99.9% |
| Free Cash Flow | -$48.0M | -61.0% |